Cargando…

DNA methylation subtypes guiding prognostic assessment and linking to responses the DNA methyltransferase inhibitor SGI-110 in urothelial carcinoma

BACKGROUND: At present, the extent and clinical relevance of epigenetic differences between upper tract urothelial carcinoma (UTUC) and urothelial carcinoma of the bladder (UCB) remain largely unknown. Here, we conducted a study to describe the global DNA methylation landscape of UTUC and UCB and to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Juan, Liang, Yuan, Fan, Jian, Xu, Chunru, Guan, Bao, Zhang, Jianye, Guo, Bin, Shi, Yue, Wang, Ping, Tan, Yezhen, Zhang, Qi, Yuan, Changwei, Wu, Yucai, Zhou, Liqun, Ci, Weimin, Li, Xuesong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290251/ https://www.ncbi.nlm.nih.gov/pubmed/35843958 http://dx.doi.org/10.1186/s12916-022-02426-w

Ejemplares similares

Immunomodulatory action of the DNA methyltransferase inhibitor SGI-110 in epithelial ovarian cancer cells and xenografts
por: Srivastava, Pragya, et al.
Publicado: (2015)

UCseek: ultrasensitive early detection and recurrence monitoring of urothelial carcinoma by shallow-depth genome-wide bisulfite sequencing of urinary sediment DNA
por: Wang, Ping, et al.
Publicado: (2023)

Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma
por: Jueliger, Simone, et al.
Publicado: (2016)

Comprehensive genomic profiling of upper tract urothelial carcinoma and urothelial carcinoma of the bladder identifies distinct molecular characterizations with potential implications for targeted therapy & immunotherapy
por: Tang, Qi, et al.
Publicado: (2023)

Construction of diagnostic and subtyping models for renal cell carcinoma by genome-wide DNA methylation profiles
por: Zhang, Jianye, et al.
Publicado: (2021)

Surgical techniques and oncological outcomes of pure transperitoneal laparoscopic radical nephroureterectomy for upper urinary tract urothelial carcinoma
por: Yuan, Changwei, et al.
Publicado: (2023)

Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of DNA methylation
por: Zhang, Lei, et al.
Publicado: (2015)

Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma
por: Wong, Jonathan, et al.
Publicado: (2022)

Molecular Modeling Studies of the Novel Inhibitors of DNA Methyltransferases SGI-1027 and CBC12: Implications for the Mechanism of Inhibition of DNMTs
por: Yoo, Jakyung, et al.
Publicado: (2013)

Aristolochic acid mutational signature defines the low-risk subtype in upper tract urothelial carcinoma
por: Lu, Huan, et al.
Publicado: (2020)

Single-cell atlases link macrophages and CD8(+) T-cell subpopulations to disease progression and immunotherapy response in urothelial carcinoma
por: Liang, Yuan, et al.
Publicado: (2022)

Copy Number Signatures and Clinical Outcomes in Upper Tract Urothelial Carcinoma
por: Guan, Bao, et al.
Publicado: (2021)

Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors
por: Papadatos-Pastos, Dionysis, et al.
Publicado: (2022)

Immunomodulatory activity of SGI-110: a basis for novel chemo-immunotherapeutic combinations in cancer treatment
por: Covre, Alessia, et al.
Publicado: (2013)

Simultaneous Modeling of Biomarker and Toxicity Response Predicted Optimal Regimen of Guadecitabine (SGI‐110) in Myeloid Malignancies
por: Xu, Cong, et al.
Publicado: (2017)

The Evolution of Clinicopathological Diagnostic Features of Upper Tract Urothelial Carcinoma in China: A Summary of 2561 Cases in the Last 20 Years
por: Xu, Chunru, et al.
Publicado: (2022)

Potassium bisperoxo (1,10-phenanthroline) oxovanadate suppresses proliferation of hippocampal neuronal cell lines by increasing DNA methyltransferases
por: Tian, Xiao-Li, et al.
Publicado: (2019)

Pyroptosis-Related Signature Predicts Prognosis and Immunotherapy Efficacy in Muscle-Invasive Bladder Cancer
por: Zhang, Qi, et al.
Publicado: (2022)

Two New SGI1-LK Variants Found in Proteus mirabilis and Evolution of the SGI1-HKL Group of Salmonella Genomic Islands
por: de Curraize, Claire, et al.
Publicado: (2020)

Regional gain and global loss of 5-hydroxymethylcytosine coexist in genitourinary cancers and regulate different oncogenic pathways
por: Qi, Jie, et al.
Publicado: (2022)

3rd European Cray/SGI MPP Workshop
Publicado: (1997)

5th European SGI-Cray MPP Workshop
Publicado: (1999)

SGI: automatic clinical subgroup identification in omics datasets
por: Buyukozkan, Mustafa, et al.
Publicado: (2021)

Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients
por: Xiong, Gengyan, et al.
Publicado: (2018)

DNA methylation and DNA methyltransferases
por: Edwards, John R., et al.
Publicado: (2017)

Robotic ureteral reimplantation for the management of ureterovaginal fistula: four cases at a single center
por: Yuan, Changwei, et al.
Publicado: (2021)

Recent progress in DNA methyltransferase inhibitors as anticancer agents
por: Zhang, Zhixiong, et al.
Publicado: (2022)

DNA methyltransferases and their roles in tumorigenesis
por: Zhang, Wu, et al.
Publicado: (2017)

DNA Methyltransferase Inhibitors: Catalysts For Antitumour Immune Responses
por: Dan, Huimin, et al.
Publicado: (2019)

Erratum for de Curraize et al., “Two New SGI1-LK Variants Found in Proteus mirabilis and Evolution of the SGI1-HKL Group of Salmonella Genomic Islands”
por: de Curraize, Claire, et al.
Publicado: (2020)

Design, Synthesis and Biological Evaluation of 4-Amino-N-(4-aminophenyl)benzamide Analogues of Quinoline-Based SGI-1027 as Inhibitors of DNA Methylation
por: Rilova, Elodie, et al.
Publicado: (2014)

DNA methyltransferase-1 in acute myeloid leukaemia: beyond the maintenance of DNA methylation
por: Li, Mengyuan, et al.
Publicado: (2022)

DNMTs inhibitor SGI-1027 induces apoptosis in Huh7 human hepatocellular carcinoma cells
por: Sun, Ning, et al.
Publicado: (2018)

Association of DNA Methyltransferases 3A and 3B Polymorphisms, and Plasma Folate Levels with the Risk of Urothelial Carcinoma
por: Chung, Chi-Jung, et al.
Publicado: (2014)

DNA methyltransferases are complementary in maintaining DNA methylation in embryonic stem cells
por: Liu, Yuhan, et al.
Publicado: (2022)

The RNA N6-Methyladenosine Methyltransferase METTL3 Promotes the Progression of Kidney Cancer via N6-Methyladenosine-Dependent Translational Enhancement of ABCD1
por: Shi, Yue, et al.
Publicado: (2021)

Increased chromosomal instability characterizes metastatic renal cell carcinoma
por: Ma, Qin, et al.
Publicado: (2020)

DNA Methyltransferase 3b Accelerates the Process of Atherosclerosis
por: Zhu, Ling, et al.
Publicado: (2022)

SPIRE – combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trial
por: Crabb, Simon, et al.
Publicado: (2018)

Oct4 regulates DNA methyltransferase 1 transcription by direct binding of the regulatory element
por: Wu, Fengrui, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m1m1r6l6243dbte9fv88chnvv9